Imricor Medical Systems Inc. (ASX:IMR)

$1.02

right-arrow Created with Sketch. -0.055 (-5.12%)
MCAP $146.0M
Last trade 12.31pm 06/12/2021 20mins delayed

Latest Announcements

29/11/2021 Price SensitivePSIMRImricor Medical Systems Inc.
24/11/2021 Price SensitivePSIMRImricor Medical Systems Inc.
28/10/2021 Price SensitivePSIMRImricor Medical Systems Inc.
27/10/2021IMRImricor Medical Systems Inc.
20/10/2021IMRImricor Medical Systems Inc.
14/10/2021IMRImricor Medical Systems Inc.
12/10/2021 Price SensitivePSIMRImricor Medical Systems Inc.
12/10/2021 Price SensitivePSIMRImricor Medical Systems Inc.

Company Overview

Imricor Medical Systems, Inc. is a United States-based medical device company. The Company is focused on designing, manufacturing and selling magnetic resonance imaging (MRI)-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include the Advantage- mitral regurgitation (MR) electrophysiology (EP) Recorder/Stimulator System, the Vision-MR Ablation Catheter and the Vision-MR Dispersive Electrode. Its Advantage-MR EP Recorder/Stimulator is an electrophysiology amplifier and recording system with integrated cardiac stimulator. Vision-MR Ablation Catheter is an irrigated tip, single-use radiofrequency (RF) ablation catheter. Vision-MR Dispersive Electrode is a dispersive electrode. The Advantage-MR EP Recorder/Stimulator System is capital equipment which can be used in multiple procedures.

IMR in the news

Imricor Medical Systems (IMR) signs an agreement with MiRTLE Medical for its…
Imricor Medical Systems (IMR) closes a $16.5 million placement ahead of an…
Imricor Medical Systems (IMR) signs a sales distribution deal with Norway’s NordicNeuroLabHeadquartered…
Imricor Medical Systems (IMR) has entered into a distribution agreement with medical…

Search Previous Announcements